Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review
Feb 3, 2026
23:23
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
Hematologic Oncology Update